Epidemiology

You have full text access to this OnlineOpen article

Flavonoid intake and ovarian cancer risk in a population-based case-control study

  1. Margaret A. Gates1,2,†,*,
  2. Allison F. Vitonis3,
  3. Shelley S. Tworoger1,2,
  4. Bernard Rosner1,4,
  5. Linda Titus-Ernstoff5,
  6. Susan E. Hankinson1,2,
  7. Daniel W. Cramer2,3

Article first published online: 11 NOV 2008

DOI: 10.1002/ijc.24151

Issue

International Journal of Cancer

International Journal of Cancer

Volume 124, Issue 8, pages 1918–1925, 15 April 2009

Additional Information

How to Cite

Gates, M. A., Vitonis, A. F., Tworoger, S. S., Rosner, B., Titus-Ernstoff, L., Hankinson, S. E. and Cramer, D. W. (2009), Flavonoid intake and ovarian cancer risk in a population-based case-control study. Int. J. Cancer, 124: 1918–1925. doi: 10.1002/ijc.24151

Author Information

  1. 1

    Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

  2. 2

    Department of Epidemiology, Harvard School of Public Health, Boston, MA

  3. 3

    Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA

  4. 4

    Department of Biostatistics, Harvard School of Public Health, Boston, MA

  5. 5

    Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH

  1. †

    Fax: +617-525-2008

*Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115, USA

Publication History

  1. Issue published online: 12 FEB 2009
  2. Article first published online: 11 NOV 2008
  3. Manuscript Accepted: 24 OCT 2008
  4. Manuscript Received: 25 MAR 2008

Funded by

  • National Cancer Institute, National Institutes of Health. Grant Numbers: R01 CA054419, P50 CA105009, T32 CA009001, R25 CA098566

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (104K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Zora Djuric, Richard K. Severson, Ikuko Kato, Association of Dietary Quercetin With Reduced Risk of Proximal Colon Cancer, Nutrition and Cancer, 2012, 64, 3, 351

    CrossRef

  2. 2
    Dominique Trudel, David P. Labbé, Isabelle Bairati, Vincent Fradet, Laurent Bazinet, Bernard Têtu, Green tea for ovarian cancer prevention and treatment: A systematic review of the in vitro, in vivo and epidemiological studies, Gynecologic Oncology, 2012,

    CrossRef

  3. 3
    Kana Suou, Fuminori Taniguchi, Yukiko Tagashira, Tomoiki Kiyama, Naoki Terakawa, Tasuku Harada, Apigenin inhibits tumor necrosis factor α–induced cell proliferation and prostaglandin E2 synthesis by inactivating NFκB in endometriotic stromal cells, Fertility and Sterility, 2011, 95, 4, 1518

    CrossRef

  4. 4
    Nathália G. Amado, Bárbara F. Fonseca, Débora M. Cerqueira, Vivaldo Moura Neto, José G. Abreu, Flavonoids: Potential Wnt/beta-catenin signaling modulators in cancer, Life Sciences, 2011, 89, 15-16, 545

    CrossRef

  5. 5
    Cheng-Wei Lin, Shing-Chuan Shen, Chih-Chiang Chien, Liang-Yo Yang, Lin-Ting Shia, Yen-Chou Chen, 12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCα/ERK/NF-κB-dependent MMP-9 expression, Journal of Cellular Physiology, 2010, 225, 2
    Direct Link:
  6. 6
    Sang-Joon Choi, Jun-Shik Choi, The Promotive Effects of Antioxidative Apigenin on the Bioavailability of Paclitaxel for Oral Delivery in Rats, Biomolecules and Therapeutics, 2010, 18, 4, 469

    CrossRef

View Full Article (HTML) Get PDF (104K)